Literature DB >> 2344296

Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study.

J E Eichner1, L H Kuller, R E Ferrell, E N Meilahn, M I Kamboh.   

Abstract

The apolipoprotein (apo) E structural locus has been shown to influence concentrations of total cholesterol, apo B, and low density lipoprotein (LDL) cholesterol in population studies. Apo E has six phenotypes resulting from three common alleles at this locus. In the present study, we have typed 473 healthy white women for apo E. At baseline in 1984, all women were premenopausal. To date, 109 of these women have become postmenopausal and are not on hormone therapy. Statistical analyses were done on both pre- and postmenopausal groups to assess the influence of menopausal status in combination with the apo E locus on lipid profile. Nine lipoprotein lipids and apolipoproteins were categorized by three apo E phenotypes: apo E3-2, apo E3-3, and apo E4-3. These were compared in analysis of variance. At baseline, the apo E3-2 phenotype showed the lowest average concentrations of total cholesterol (170 mg/dl), apo B (80 mg/dl), and LDL cholesterol (91 mg/dl), while the apo E4-3 phenotype demonstrated the highest average concentrations of total cholesterol (192 mg/dl), apo B (104 mg/dl), and LDL cholesterol (116 mg/dl) (p less than or equal to 0.0004). Apo E3-3 homozygotes were intermediate on all three quantitative variables. The postmenopausal subset showed the same trends by phenotype, with overall increases in total cholesterol, apo B, LDL cholesterol, and triglycerides, regardless of phenotype. Women who remained premenopausal generally showed smaller increases in these same measures. Our results suggest that, on average, the lower lipoprotein values for the apo E3-2 phenotype are maintained through early menopause despite a worsening of lipid profiles for all women as they age.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344296     DOI: 10.1161/01.atv.10.3.379

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  6 in total

1.  A polymorphism of apolipoprotein E (APOE) gene is associated with age at natural menopause in Caucasian females.

Authors:  Li-Na He; Robert R Recker; Hong-Wen Deng; Volodymyr Dvornyk
Journal:  Maturitas       Date:  2008-12-05       Impact factor: 4.342

2.  Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories.

Authors:  Brian J Lopresti; Elizabeth M Campbell; Zheming Yu; Stewart J Anderson; Ann D Cohen; Davneet S Minhas; Beth E Snitz; Sarah K Royse; Carl R Becker; Howard J Aizenstein; Chester A Mathis; Oscar L Lopez; William E Klunk; Dana L Tudorascu
Journal:  Neurobiol Aging       Date:  2020-05-31       Impact factor: 4.673

3.  Genotype-environment interaction: apolipoprotein E (ApoE) gene effects and age as an index of time and spatial context in the human.

Authors:  K E Zerba; R E Ferrell; C F Sing
Journal:  Genetics       Date:  1996-05       Impact factor: 4.562

4.  LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.

Authors:  Susan J Murdoch; Andrew P Boright; Andrew D Paterson; Bernard Zinman; Michael Steffes; Patricia Cleary; Karen Edwards; Santica S Marcovina; Jonathan Q Purnell; John D Brunzell
Journal:  Atherosclerosis       Date:  2006-06-05       Impact factor: 5.162

5.  Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease.

Authors:  Taranjit Singh Rai; Madhu Khullar; B S Sehrawat; Monica Ahuja; Praveen Kumar Sharma; Rajesh Vijayvergiya; Anil Grover
Journal:  Mol Cell Biochem       Date:  2008-04-09       Impact factor: 3.396

6.  Dietary intake in the Personalized Medicine Research Project: a resource for studies of gene-diet interaction.

Authors:  Lacie Strobush; Richard Berg; Deanna Cross; Wendy Foth; Terrie Kitchner; Laura Coleman; Catherine A McCarty
Journal:  Nutr J       Date:  2011-01-28       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.